BMS-863233 Uses, Dosage, Side Effects and more
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
| Trade Name | BMS-863233 |
| Generic | BMS-863233 |
| Type | |
| Formula | C14H12ClN3O2 |
| Weight | Average: 289.717 Monoisotopic: 289.06180435 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
